You're kicking a dead horse. This delivery system didn't work for liver cancer and it wont work for breast caner. Management will drag these tests out as long as the money lasts. Next thing will be a revers split to make it look more promising to the next bunch of unaware investors. I was fortunate and got out before I lost my shirt, and my pants.